Suchen und filtern

Gefundene Studien

CONKO-007 Randomisierte Phase-III-Studie zum Stellenwert einer Radiochemotherapie nach Induktionschemotherapie beim lokal begrenzten, inoperablen Pankreaskarzinom: Chemotherapie gefolgt von Radiochemotherapie im Vergleich zur alleinigen Chemotherapie CONKO-007 · Rekrutierung beendet Studie anzeigen

RAP-Trial Ramucirumab, Avelumab, Paclitaxel (RAP) as second line treatment in gastro-esophageal adenocarcinoma: a phase II trial of the AIO AIO-STO-0218 · Rekrutierung beendet Studie anzeigen

RE-ExPEL A study of Ramucirumab beyond progression plus TAS- 102 in patients with advanced or metastatic adenocarcinoma of the stomach or the gastroesophageal junction, after treatment failure on a ramucirumab based therapy AIO-STO-0419/ass · Rekrutierung beendet Studie anzeigen

RAMOS-Study A randomized, multicenter open label phase II trial of Paclitaxel + Ramucirumab versus Paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with Fluoropyrimidine and Platinum-based drugs AIO-STO-0216/ass · Rekrutierung beendet Studie anzeigen

DANTE-Trial (Phase ll) A randomized, open-label Phase II efficacy and safety study of Atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophago-gastric junction (MO30039) AIO-STO-0317 · Rekrutierung beendet Studie anzeigen

RAMSES – FLOT7 Perioperative RAMucirumab in combination with FLOT versus FLOT alone for reSEctable eSophagogastric adenocarcinoma - A phase II/III trial of the AIO AIO-STO-0315/ass · Rekrutierung beendet Studie anzeigen

CaboCHECK Cabozantinib in adult patients with advanced renal cell carcinoma following prior systemic check point inhibition therapy: a retrospective, non-interventional study AIO-NZK-0118/ass · Rekrutierung beendet Studie anzeigen

AIO-NET-0113 A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter, Double-blind Study to Evaluate the Efficacy and Safety of Telotristat Etiprate (LX1606) in Patients with Carcinoid Syndrome (CS) Refractory to Somatostatin Analog (SSA) Therapy AIO-NET-0113 · Rekrutierung beendet Studie anzeigen

SPINET-Tria A Phase 3, prospective, randomized, double-blind, multi-center study of the efficacy and safety of lanreotide Autogel/Depot 120 mg plus BSC vs. placebo plus BSC for tumour control in subjects with well differentiated, metastatic and/or unresectable, typical or atypical, lung neuroendocrine tumours. AIO-NET-0116/ass · Rekrutierung beendet Studie anzeigen

SEQTOR-Study Randomized open label study to compare the efficacy and safety of everolimus followed by chemotherapy with STZ-5FU upon progression or the reverse sequence, chemotherapy with STZ-5FU followed by everolimus upon progression, in advanced progressive pNETs AIO-NET-0215/ass · Rekrutierung beendet Studie anzeigen